To include your compound in the COVID-19 Resource Center, submit it here.

Team describes off-target effects of Bial's FAAH inhibitor

In a paper published in Science, researchers characterized off-target activities of fatty acid amide hydrolase (FAAH) inhibitor BIA 10-2474 that they say may have played a role in the compound’s clinical neurotoxicity that led

Read the full 342 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers